넥스트바이오메디컬
28,000KRWMarket close of 10/27 (Tue)
Up +3.13%+850KRWMarket close of 10/27 (Tue)
- Open
- 27,750
- High
- 29,300
- Low
- 27,500
- Day range
- Day range low 27,500 high 29,300, open 27,750, close 28,000, previous close 27,150
- Volume
- 2×10K shares
- 699.32 million KRW 0.82× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
3%1-year close range 25,550 to 98,000 won, 3% up from the low
3% of the way up from the lowest close in 1 year (252 sessions) · -71.4% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Earningsnot verifiedOutside financial data coverage, so not verified
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range+3.13%+3.13%, 0.8× the usual (20-session average ±3.83%)That day +3.13% · usual ±3.83% · large-move threshold ±7.7%
The other 2 are within the usual range
- Trading value0.8×usual range
- Foreign & institutional+100.00 million KRWusual range
See the full check report
Same sector · 의료·정밀기기
Up +2.12%· 64 of 101 stocks up, preferred shares excluded · trading value 174.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 디아이 | Close over the last 20 sessions +2.9% | Up +4.71% | 19.5B KRW |
| 티에스이 | Close over the last 20 sessions -10.0% | Up +7.88% | 19.1B KRW |
| 노을 | Close over the last 20 sessions +29.9% | Down -7.14% | 15.8B KRW |
| 씨어스 | Close over the last 20 sessions +5.0% | Down -5.57% | 15.2B KRW |
| 빅텍 | Close over the last 20 sessions +5.5% | Down -0.16% | 14.6B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.